Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
InCoax | INCOAX | Mar 27, 2024 | 1.86 | 0.00 |
InDex Pharmaceuticals Holding | INDEX | Mar 27, 2024 | 0.30 | -1.32 |
Industrivärden A | INDUA | Mar 27, 2024 | 373.80 | +0.81 |
Industrivärden C | INDUC | Mar 27, 2024 | 373.80 | +0.81 |
Indutrade | INDT | Mar 27, 2024 | 292.30 | +0.38 |
Infant Bacterial Therapeutics B | IBTB | Mar 27, 2024 | 77.00 | +1.58 |
Infracom | INFRA | Mar 27, 2024 | 32.40 | -0.31 |
Infrea | INFREA | Mar 27, 2024 | 11.00 | +2.80 |
Inhalation Sciences | ISAB | Mar 27, 2024 | 3.44 | +2.08 |
Inission B | INISSB | Mar 27, 2024 | 42.20 | -1.40 |
Initiator Pharma | INIT | Mar 27, 2024 | 8.98 | +0.45 |
Insplorion | INSP | Mar 27, 2024 | 2.34 | -4.10 |
Instalco | INSTAL | Mar 27, 2024 | 43.56 | +1.87 |
Integrum B | INTEGB | Mar 27, 2024 | 50.50 | +0.20 |
Intellego Technologies | INT | Mar 27, 2024 | 27.85 | -2.96 |
International Petroleum Corp. | IPCO | Mar 27, 2024 | 124.60 | -0.24 |
Intervacc | IVACC | Mar 27, 2024 | 3.67 | +0.14 |
Intrum | INTRUM | Mar 27, 2024 | 25.33 | -3.91 |
Invent Medic | IMS | Mar 27, 2024 | 0.73 | +2.54 |
Investor A | INVEA | Mar 27, 2024 | 266.80 | -0.07 |
Investor B | INVEB | Mar 27, 2024 | 269.85 | +0.13 |
INVISIO | IVSO | Mar 27, 2024 | 250.00 | +0.40 |
Invoicery Group AB | FRILAN | Mar 27, 2024 | 3.93 | +2.08 |
Inwido | INWI | Mar 27, 2024 | 146.50 | +3.24 |
Irisity | IRIS | Mar 27, 2024 | 3.98 | +1.02 |
IRLAB Therapeutics A | IRLABA | Mar 27, 2024 | 16.20 | -3.28 |
Isofol Medical | ISOFOL | Mar 27, 2024 | 0.76 | 0.00 |
ITAB Shop Concept | ITAB | Mar 27, 2024 | 19.95 | +1.01 |
iZafe Group B | IZAFEB | Mar 27, 2024 | 0.24 | +11.63 |
Jetpak Top Holding | JETPAK | Mar 27, 2024 | 94.40 | -0.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.